Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

DNA-PK

The DNA-dependent protein kinase (DNA-PK) is a serine/threonine protein kinase consisting of a catalytic subunit (DNA-PKcs) and a Ku heterodimer that is made up of the Ku70 and Ku80 subunits. DNA-PK was accidentally discovered after researchers studying translation found that double-stranded DNA (dsDNA) contaminated their preparations, leading to the phosphorylation of specific proteins.

Nedisertib
TQ00311637542-33-6
Nedisertib (M3814) is a specific inhibitor of DNA-dependent protein kinase (DNA-PK) with IC50 value less than 3 nM.
    Inquiry
    TargetMol | Inhibitor Hot
    TargetMol | Citations Cited
    LY294002
    T2008154447-36-6
    LY294002 (SF 1101) is a broad-spectrum inhibitor of PI3K, inhibiting PI3Kα, PI3Kδ, and PI3Kβ (IC50=0.5 0.57 0.97 μM). LY294002 is also an inhibitor of DNA-PK (IC50=1.4 μM) and an inhibitor of CK2 (IC50=98 nM). LY294002 activates apoptosis and autophagy.
    • $34
    In Stock
    Size
    QTY
    TargetMol | Inhibitor Hot
    TargetMol | Citations Cited
    Wortmannin
    T628319545-26-7
    Wortmannin (SL-2052) is a PI3K inhibitor (IC50=3 nM) that is covalent and irreversible. Wortmannin is also an inhibitor of PlK1 and PlK3 (IC50=5.8 48 nM) that blocks autophagy.
    • $40
    In Stock
    Size
    QTY
    TargetMol | Citations Cited
    PIK-75
    T2667372196-67-3
    PIK-75, a DNA-PK and PI3K inhibitor, suppresses DNA-PK(IC50=2 nM), p110α(IC50=5.8 nM) and p110γ(IC50=76 nM).
    • $38
    In Stock
    Size
    QTY
    TargetMol | Citations Cited
    STL127705
    T130171326852-06-5In house
    STL127705 (Compound L) is a potent inhibitor of the Ku 70 80 heterodimer protein, disrupting Ku70 80-DNA interaction with an IC50 of 3.5 μM, and inhibiting Ku-dependent DNA-PKCS kinase activation with an IC50 of 2.5 μM.
    • $116
    In Stock
    Size
    QTY
    AZD-7648
    T71222230820-11-6
    AZD-7648 is an inhibitor of DNA-dependent protein kinase (DNA-PK) with the IC50 of 0.63 nM in an enzyme assay,has anti-tumor activity.
    • $34
    In Stock
    Size
    QTY
    Torin 1
    T60451222998-36-8
    Torin 1 is an effective inhibitor of mTORC1 2 with (IC50: 2 nM 10 nM); has 1000-fold selectivity for mTOR than PI3K.
    • $30
    In Stock
    Size
    QTY
    TargetMol | Inhibitor Hot
    TargetMol | Citations Cited
    AZD 6482
    T60871173900-33-8
    AZD 6482 (KIN-193) is a potent and selective inhibitor of p110β and PI3Kβ with IC50 values ​​of 0.69nM and 10nM, respectively. AZD 6482 is particularly effective in blocking AKT signaling and tumor growth dependent on p110β activation or PTEN loss.
    • $31
    In Stock
    Size
    QTY
    KU-57788
    T6276503468-95-9
    NU7441 (KU-57788 (NU7441)) is a highly effective and specific DNA-PK inhibitor (IC50: 14 nM).
    • $34
    In Stock
    Size
    QTY
    TargetMol | Inhibitor Sale
    TargetMol | Citations Cited
    torin 2
    T61001223001-51-1
    Torin 2(IC50=0.25 nM), a specific and effective mTOR inhibitor, is the 800-fold greater specific activity for mTOR than PI3K and improves pharmacokinetic properties. The EC50 of Torin 2 for ATM ATR DNA-PK inhibition is 28 nM 35 nM 118 nM, respectively.
    • $35
    In Stock
    Size
    QTY
    TargetMol | Inhibitor Sale
    TargetMol | Citations Cited
    VX-984
    T110671476074-39-1
    VX-984 (M9831) is an oral, selective DNA-PK inhibitor that can cross the blood-brain barrier. VX-984 inhibited the conjugation of non-homologous terminal NHEJ and acted on DSBs to break DNA double strand. VX-984 is commonly seen in glioblastoma (GBM) and non-small cell lung cancer (NSC-LC) studies.
    • $180
    In Stock
    Size
    QTY
    TargetMol | Inhibitor Hot
    Samotolisib
    T68831386874-06-1
    Samotolisib (LY3023414) is an oral ATP competitive inhibitor of the class I PI3K isoforms, DNA-PK, and mTOR. Samotolisib (LY3023414) has been used in trials studying the treatment of Neoplasm, Solid Tumor, COLON CANCER, BREAST CANCER, and Advanced Cancer, among others.
    • $41
    In Stock
    Size
    QTY
    TargetMol | Inhibitor Sale
    KU-55933
    T2685587871-26-9
    KU-55933 (ATM Kinase Inhibitor) is an ATM inhibitor (IC50=12.9 nM; Ki=2.2 nM) that is selective and ATP-competitive. KU-55933 induces apoptosis and has antitumor effects.
    • $43
    In Stock
    Size
    QTY
    TargetMol | Citations Cited
    pik-90
    T2461677338-12-4
    PIK-90, a DNA-PK and PI3K inhibitor, suppresses p110α( IC50=11 nM), p110γ(IC50=18 nM) and DNA-PK(IC50=13 nM) .
    • $39
    In Stock
    Size
    QTY
    PI-103
    T6143371935-74-9
    PI-103 is a potent, cell-permeable, ATP-competitive inhibitor of PI3K family members (IC50s: 2 3 3 15 30 23 nM for p110α β δ γ, mTOR, and DNA-PK).
    • $52
    In Stock
    Size
    QTY
    nu 7026
    T2433154447-35-5
    NU 7026 (DNA-PK Inhibitor II) is an effective DNA-PK inhibitor (IC50: 0.23 μM, in cell-free assays), 60-fold selective for DNA-PK than PI3K and no inhibition against both ATM and ATR.
    • $33
    In Stock
    Size
    QTY
    PI3K-IN-1
    T18261349796-36-6
    PI3K-IN-1 (Voxtalisib Analogue) is a dual inhibitor of mTOR PI3K, mostly for p110γ , also inhibits DNA-PK and mTOR.
    • $30
    In Stock
    Size
    QTY
    SF2523
    T39861174428-47-7
    SF2523 is a highly selective and potent inhibitor (SF2523) with improved physicochemical properties, excellent aqueous solubility, and biological efficacy. It is typically used in genome editing [CRISPR Cas Solution] technology and can effectively enhance the efficiency of this process.
    • $31
    In Stock
    Size
    QTY
    Leniolisib
    T51661354690-24-6
    Leniolisib (CDZ173) (CDZ173) is a potent and selective PI3Kδ inhibitor (IC50: 11 nM).
    • $72
    In Stock
    Size
    QTY
    onatasertib
    T33511228013-30-6
    Onatasertib (CC223) is an orally available mTOR inhibitor with potential antitumor activity. Onatasertib inhibits the activity of mTOR, which may result in the induction of tumor cell apoptosis and a decrease in tumor cell proliferation. Onatasertib is a potent mTOR kinase inhibitor (IC50: 16 nM), with >150-fold sensitivity than the related lipid kinase PI3Kα (IC50: 4 μM).
    • $35
    In Stock
    Size
    QTY
    NU6027
    T6612220036-08-8
    NU6027 is a potent ATR CDK inhibitor, inhibits CDK1 2, ATR and DNA-PK with Ki of 2.5 μM 1.3 μM, 0.4 μM and 2.2 μM, enter cells more readily than the 6-aminopurine-based inhibitors.
    • $37
    In Stock
    Size
    QTY
    TargetMol | Inhibitor Sale
    BAY-8400
    T9498
    BAY-8400 is a potent, selective, and orally active DNA-dependent protein kinase (DNA-PK) inhibitor (IC50 = 81 nM) that demonstrates synergistic efficacy when combined with targeted alpha therapies. BAY-8400 is applicable for cancer research [1].
    • $77
    In Stock
    Size
    QTY
    TargetMol | Inhibitor Sale
    voxtalisib
    T7014934493-76-2
    Voxtalisib (XL765) (SAR245409, XL765) is a dual inhibitor of mTOR PI3K, mostly for p110γ with IC50 of 9 nM; also inhibits DNA-PK and mTOR. Phase 1 2.
    • $32
    In Stock
    Size
    QTY
    KU-0060648
    T6557881375-00-4
    KU-0060648 is a dual inhibitor of DNA-PK and PI3Kα, PI3Kβ, PI3Kδ with IC50 values of 8.6 nM, 4 nM, 0.5 nM, and 0.1 nM respectively, and demonstrates less inhibition of PI3Kγ with an IC50 of 0.59 μM.
    • $54
    In Stock
    Size
    QTY
    TargetMol | Inhibitor Sale